

Feature | Ozempic | Wegovy |
|---|---|---|
Active ingredient | Semaglutide | Semaglutide |
Main use | Type 2 diabetes | Weight management |
Max weekly dose | ~2.0 mg | ~2.4 mg |
Typical weight loss | ~6-10% body weight | ~12-15%+ body weight |
Heart & kidney benefit | Yes (in diabetics) | Yes (in obesity + CV risk) |
Approved by FDA? | Diabetes | Obesity |
Form available | Injection | Injection + now pill option in the USA |
Side effects more common | Fewer overall | More at higher doses |
